Literature DB >> 14164484

THE APPLICATION OF TISSUE CULTURE TO THE STUDY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. II. SERUM FACTORS RESPONSIBLE FOR DEMYELINATION.

S H APPEL, M B BORNSTEIN.   

Abstract

1. In the presence of a source of complement, the gamma 2 globulin fraction of rabbit EAE serum results in complete demyelination of myelinated cultures of rat cerebellum. Exposure of the serum to homologous or heterologous brain specifically removes the myelinotoxic activity whereas exposure to non-nervous tissue does not. Polylysine has no effect upon the cultures or upon the demyelinative potency of EAE, whereas heparin inhibits activity presumably through an effect on complement. 2. With the fluorescent antibody technique, the EAE globulins are specifically localized to the myelin sheaths and glial cell membranes during the process of demyelination. As demyelination proceeds, the globulins become localized within the neuroglia in a homogeneous manner which contrasts sharply with the punctate pattern observed in control experiments. 3. The "delayed sensitivity" and classical antibody interpretations of experimental allergic encephalomyelitis are discussed. It is suggested that several factors may be responsible for the pathogenesis of EAE, one of which may well be a myelinotoxic antibody.

Entities:  

Keywords:  CEREBELLUM; DEMYELINATION; ENCEPHALOMYELITIS; EXPERIMENTAL LAB STUDY; FLUORESCENT ANTIBODY TECHNIC; FREUND'S ADJUVANT; GAMMA GLOBULIN; HEPARIN; HYPERSENSITIVITY; MICE; MICROSCOPY, FLUORESCENCE; PEPTIDES; PHARMACOLOGY; RATS; SPINAL CORD

Mesh:

Substances:

Year:  1964        PMID: 14164484      PMCID: PMC2137833          DOI: 10.1084/jem.119.2.303

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Encephalitogenic factor in experimental "allergic" encephalomyelitis.

Authors:  E A CASPARY; E J FIELD
Journal:  Nature       Date:  1963-03-23       Impact factor: 49.962

2.  Isoagglutinins associated with ABO erythroblastosis.

Authors:  S KOCHWA; R E ROSENFIELD; L TALLAL; L R WASSERMAN
Journal:  J Clin Invest       Date:  1961-05       Impact factor: 14.808

3.  Encephalitogenic activity of poly-L-lysine.

Authors:  S E KORNGUTH; D R BENNETT; H G THOMPSON; G M ZURHEIN; M A STAHMANN
Journal:  Nature       Date:  1962-03-17       Impact factor: 49.962

4.  Localization of allergic encephalomyelitis in lesions of cyanide encephalopathy.

Authors:  S LEVINE
Journal:  J Neuropathol Exp Neurol       Date:  1960-04       Impact factor: 3.685

5.  The induction of the lesions of allergic meningoencephalomyelitis in a predetermined location.

Authors:  G CLARK; L H BOGDANOVE
Journal:  J Neuropathol Exp Neurol       Date:  1955-10       Impact factor: 3.685

6.  Further study of skin reactions in rabbits with experimental allergic encephalomyelitis: reactions to tests with purified white matter fractions; use of a quantitative technique for evaluating sensitivity production of sensitization and disease by intradermal injection of antigen without adjuvants.

Authors:  B H WAKSMAN
Journal:  J Infect Dis       Date:  1956 Nov-Dec       Impact factor: 5.226

7.  A study of abnormal blood-brain permeability in experimental allergic encephalomyelitis.

Authors:  C F BARLOW
Journal:  J Neuropathol Exp Neurol       Date:  1956-04       Impact factor: 3.685

8.  Myelin-binding antibodies in experimental "allergic" encephalomyelitis.

Authors:  A L SHERWIN; M RICHTER; J B COSGROVE; B ROSE
Journal:  Science       Date:  1961-10-27       Impact factor: 47.728

9.  Serial observations on patterns of growth, myelin formation, maintenance and degeneration in cultures of new-born rat and kitten cerebellum.

Authors:  M B BORNSTEIN; M R MURRAY
Journal:  J Biophys Biochem Cytol       Date:  1958-09-25

10.  Studies on acute disseminated encephalomyelitis produced experimentally in Rhesus monkeys; complement-fixing antibodies.

Authors:  C E LUMSDEN; E A KABAT; A WOLF; A E BEZER
Journal:  J Exp Med       Date:  1950-09       Impact factor: 14.307

View more
  27 in total

1.  Interactions between immunocompetent cells and target cells or antigens.

Authors:  J R David
Journal:  Bull N Y Acad Med       Date:  1967-11

2.  Demyelination and remyelination in recurrent idiopathic polyneuropathy. An electron microscope study.

Authors:  J W Prineas
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

3.  [On the significance of the gamma G-globulin fraction in the brain tissue in subacute sclerosing leukoencephalitis].

Authors:  O Kolár; S J Dencker; M Obrucník; I Cerná; Z Skatula
Journal:  Dtsch Z Nervenheilkd       Date:  1966-03-08

4.  Immunohistochemical study of allergic encephalomyelitis.

Authors:  M B Oldstone; F J Dixon
Journal:  Am J Pathol       Date:  1968-02       Impact factor: 4.307

5.  Development and characterization of myelin in tissue culture of canine cerebellum.

Authors:  R W Storts; A Koestner
Journal:  Z Zellforsch Mikrosk Anat       Date:  1969

6.  Demyelination of the spiral ganglion cultured under anoxic conditions.

Authors:  S Kitano; H Iwai
Journal:  Arch Otorhinolaryngol       Date:  1974

7.  Experimental allergic encephalomyelitis (EAE): delayed myelination-inhibition in vitro with EAE-serum: changes in vulnerability of oligodendroglia and newly formed myelin sheaths.

Authors:  J Ulrich; M B Bornstein
Journal:  Acta Neuropathol       Date:  1973-07-11       Impact factor: 17.088

8.  The effects of canine distemper virus on explant tissue cultures of canine cerebellum.

Authors:  R W Storts; A Koestner; R A Dennis
Journal:  Acta Neuropathol       Date:  1968-07-08       Impact factor: 17.088

Review 9.  The Charcot Lecture | beating MS: a story of B cells, with twists and turns.

Authors:  Stephen L Hauser
Journal:  Mult Scler       Date:  2014-12-05       Impact factor: 6.312

10.  Copper accumulation and lipid oxidation precede inflammation and myelin lesions in N,N-diethyldithiocarbamate peripheral myelinopathy.

Authors:  Olga M Viquez; Holly L Valentine; Kalyani Amarnath; Dejan Milatovic; William M Valentine
Journal:  Toxicol Appl Pharmacol       Date:  2008-01-26       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.